Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Epstein-Barr virus (EBV), the first human oncovirus discovered in 1964, has become a focal point in virology, immunology, and oncology because of its unique biological characteristics and significant role in human diseases. As we commemorate the 60th anniversary of EBV's discovery, it is an opportune moment to reflect on the major advancements in our understanding of this complex virus. In this review, we highlight key milestones in EBV research, including its virion structure and life cycle, interactions with the host immune system, association with EBV-associated diseases, and targeted intervention strategies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11427-024-2766-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Sixty years of equine anaesthesia - are we getting better at it?
Vet Anaesth Analg
May 2025
Vetstream Ltd, Cambridge, UK.
Objective: To present the essence of the presentation 'CEPEF - what we knew then and what we know now' given at the autumn meeting of the Association of Veterinary Anaesthetists in 2024, celebrating its 60th anniversary.
Databases Used: (this is not a formal systematic review). PubMed, Scopus, Google Scholar and the 4th Confidential Enquiry into Equine Perioperative Fatalities (CEPEF4).
The epidemiological data on the incidence of gastric cancer and its mortality make it a challenge for oncologists to find new and improve existing diagnostic methods and therapies. Despite the active change of modern realities in the practice of pathomorphologist for 60 years remains unchanged authority of the P.Laurén classification of histological main types.
View Article and Find Full Text PDFFirst Constraints on General Neutrino Interactions Based on KATRIN Data.
Phys Rev Lett
June 2025
Karlsruhe Institute of Technology (KIT), Institute for Astroparticle Physics (IAP), Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany.
The precision measurement of the tritium β-decay spectrum performed by the KATRIN experiment provides a unique way to search for general neutrino interactions (GNIs). All theoretically allowed GNI terms at dimension 6 involving neutrinos are incorporated into a low-energy effective field theory, and can be identified by specific signatures in the measured tritium β spectrum. In this Letter an effective description of the impact of GNIs on the β spectrum is formulated and the first constraints on the effective GNI parameters are derived based on the 4×10^{6} electrons collected in the second measurement campaign of KATRIN in 2019.
View Article and Find Full Text PDFWss1 and Ddi1 DNA-Protein crosslink repair proteases protect Saccharomyces cerevisiae and Candida albicans against oxidative stress.
Sci Rep
July 2025
Research Laboratory of Biotechnology, Chulabhorn Research Institute, Bangkok, 10210, Thailand.
Oxidative stress is a major microbicidal mechanism of phagocytes causing molecular damages, including DNA-protein crosslinks (DPCs), toxic DNA lesions that can lead to genomic instability. DPC repair depends on Wss1 and Ddi1 proteases, so they may be critical for fungal survival in hosts, yet their roles have not been fully elucidated. In this study, the roles of Wss1 and Ddi1 under oxidative stress were examined in the model yeast Saccharomyces cerevisiae and Candida albicans, an important human fungal pathogen.
View Article and Find Full Text PDFBack to the Future-Cardiovascular Imaging From 1966 to Today and Tomorrow.
Invest Radiol
July 2025
Department of Medical Imaging, University of Toronto, Toronto, ON, Canada (B.J.W.); Toronto Joint Department of Medical Imaging, University Health Network, Toronto, ON, Canada (B.J.W.); Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany (B.J.W.); Diagnostic and Interventio
This article, on the 60th anniversary of the journal Investigative Radiology, a journal dedicated to cutting-edge imaging technology, discusses key historical milestones in CT and MRI technology, as well as the ongoing advancement of contrast agent development for cardiovascular imaging over the past decades. It specifically highlights recent developments and the current state-of-the-art technology, including photon-counting detector CT and artificial intelligence, which will further push the boundaries of cardiovascular imaging. What were once ideas and visions have become today's clinical reality for the benefit of patients, and imaging technology will continue to evolve and transform modern medicine.
View Article and Find Full Text PDF